Skip to main content
. Author manuscript; available in PMC: 2018 Nov 30.
Published in final edited form as: Vaccine. 2014 May 18;32(30):3752–3758. doi: 10.1016/j.vaccine.2014.05.031

Fig. 5. rNT-DsrAI antisera partially block binding of Fg to the surface of H. ducreyi.

Fig. 5.

Suspensions of H. ducreyi strains 35000HP (A) and HMC50 (B) were incubated with IgG purified from rNT-DsrAI antisera prior to addition of FITC-Fg (5 μg). The MFI of washed bacterial suspensions was then measured using flow cytometry and compared to the MFI of a strain not incubated with anti-rNT-DsrAI IgG (no IgG competitor, defined as 100% binding – dotted line). IgG from animals receiving adjuvant only was used as a negative control. dsrA-, FITC-Fg binding by an isogenic dsrA mutant (FX517 for strain 35000HP in A, FX530 for strain HMC50 in B). Shown are means ± standard deviations of 3 experiments performed on three consecutive days, which reflect the reactivity of anti- rNT-DsrAI obtained one week after the 4th immunization, on the day of infection. * p < 0.05 using a non-paired t-test, as compared to incubation with IgG from antisera of animals receiving adjuvant only.